Unique, practical knowledge for nurses responsible for daily management of patients with cardiovascular disease, diabetes and related conditions.

Evidence in Practice

Sunday, 12 March 2017
Atrial fibrillation patients with insulin-requiring diabetes are at greater risk of suffering a stroke or systemic embolism than those with non-insulin requiring diabetes, or no diabetes at all. While diabetes is a known risk factor for thromboembolic events, this finding sheds new light on the role of insulin in the clinical setting.
Topics covered:
Sunday, 12 March 2017

Low socioeconomic status is linked to significant reductions in life expectancy and should be considered a major risk factor for ill health and early death in national and global health policies, according to a new study of 1.7 million people.

Topics covered:
Thursday, 02 February 2017

A new study shows that increased activity in the amygdala (the part of the brain involved in stress) is associated with a greater risk of heart disease and stroke. This study provides new insights into the possible mechanism by which stress can lead to cardiovascular disease in humans.

Topics covered:
Thursday, 02 February 2017

Offering smokers a taster session at an NHS Stop Smoking Service and explaining their personal risk of developing smoking-related diseases doubles their likelihood of attending a stop smoking course.

Thursday, 02 February 2017

Liraglutide 1.2 mg has proved cost-effective when compared to alternative daily administered GLP-1 receptor agonists for the treatment of type 2 diabetes in the UK.

Topics covered:
Thursday, 02 February 2017

A French observational study has found that use of a beta-blocker early after myocardial infarction (MI) (within 48 hours) is associated with a substantial reduction in 30-day mortality in people who do not have heart failure. However, continuing with beta-blockers was not associated with a significant reduction in mortality at 1 year.

Wednesday, 04 January 2017

A new study suggests that a ‘Sit Less’ intervention ‒ breaking sitting with standing and light-intensity walking ‒ may be an alternative to structured exercise to promote blood sugar control in patients with type 2 diabetes, giving improved 24-hour glucose levels and improved insulin sensitivity.

Topics covered:
Wednesday, 04 January 2017

Adding evolocumab to optimised statin therapy results in statistically significant regression of atherosclerosis in patients with coronary artery disease, according to results from the GLAGOV phase 3 trial.

Topics covered:

Article search and filter